Journal
Neuro-Oncology Advances
Publication Date
1-1-2023
Volume
5
Issue
1
First Page
vdad088
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdad088
Rights and Permissions
Subhajit Ghosh and others, A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma, Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad088, https://doi.org/10.1093/noajnl/vdad088. https://academic.oup.com/noa/article/5/1/vdad088/7226260?login=true. © The Author(s) 2023. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Ghosh, Subhajit; Johanns, Tanner M; Chheda, Milan G; Liu, Eric; Butt, Omar; Abraham, Christopher; Badiyan, Shahed; Huang, Yi; DeNardo, David; Kim, Albert H; Hallahan, Dennis; Thotala, Dinesh; and Huang, Jiayi, "A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma." Neuro-Oncology Advances. 5, 1. vdad088 (2023).
https://digitalcommons.wustl.edu/oa_4/2142
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
